SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Justin Curran who wrote (537)5/6/1998 2:25:00 PM
From: Saracen  Respond to of 1185
 
I am told by a broker in Vancouver who follows NRT that we may not see the stock trading again until Friday. This is because of some details (?) that still need to be worked out with the new major drug company partner. He also says that the rumor is still that Hoffman LaRoche is the company. With what is currently going on with biotech stocks, this could be HUGELY positive for the stock.

For what it's worth.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News